Compare Healthcare Services Group, Inc. (HCSG) vs Solventum Corporation (SOLV) Stock

Solventum Corporation (SOLV) offers the better valuation at 8.4x trailing P/E (11.5x forward), making it the more compelling value choice. Analysts rate Healthcare Services Group, Inc. (HCSG) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Solventum Corporation (SOLV) is the cheapest at 8.4x versus Healthcare Services Group, Inc. at 26.9x. On forward P/E, Solventum Corporation is actually cheaper at 11.5x.

Over the past 5 years, Solventum Corporation (SOLV) delivered a total return of -7.3%, compared to -22.3% for Healthcare Services Group, Inc. (HCSG). A $10,000 investment in SOLV five years ago would be worth approximately $9K today (assuming dividends reinvested). Over 10 years, the gap is even starker: SOLV returned -7.2% versus HCSG's -23.5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Healthcare Services Group, Inc. (HCSG) is the lower-risk stock at 0.74β versus Solventum Corporation's 0.97β — meaning SOLV is approximately 31% more volatile than HCSG relative to the S&P 500. On balance sheet safety, Healthcare Services Group, Inc. (HCSG) carries a lower debt/equity ratio of 3% versus 100% for Solventum Corporation — giving it more financial flexibility in a downturn.

Solventum Corporation (SOLV) is the more profitable company, earning 18.7% net margin versus 3.2% for Healthcare Services Group, Inc. — meaning it keeps 18.7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SOLV leads at 26.2% versus 2.6% for HCSG. At the gross margin level — before operating expenses — SOLV leads at 53.5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Solventum Corporation (SOLV) trades at 11.5x forward P/E versus 22.5x for Healthcare Services Group, Inc. — 11.0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SOLV: 29.1% to $95.80.

None of the stocks in this comparison currently pay a material dividend. All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Healthcare Services Group, Inc. (HCSG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.74)). Both have compounded well over 10 years (HCSG: -23.5%, SOLV: -7.2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both. In terms of investment character: HCSG is a small-cap quality compounder stock; SOLV is a mid-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.